Pharma BD Deal Intelligence

Merck & Co. Inc. / Sirna Therapeutics Inc.

2006 · Acquisition/Merger · $1.1B · Complete

RNAi technology; $13/share, 102% premium; later written off and divested to Alnylam

Key facts

• Announced Oct 30, 2006
• Deal value $1.1B
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals